These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21413908)

  • 1. Therapeutic potential of FtsZ inhibition: a patent perspective.
    Awasthi D; Kumar K; Ojima I
    Expert Opin Ther Pat; 2011 May; 21(5):657-79. PubMed ID: 21413908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel solid synthesis of inhibitors of the essential cell division FtsZ enzyme as a new potential class of antibacterials.
    Paradis-Bleau C; Beaumont M; Sanschagrin F; Voyer N; Levesque RC
    Bioorg Med Chem; 2007 Feb; 15(3):1330-40. PubMed ID: 17157508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective GTP-replacing FtsZ inhibitors and antibacterial mechanism of action.
    Artola M; Ruiz-Avila LB; Vergoñós A; Huecas S; Araujo-Bazán L; Martín-Fontecha M; Vázquez-Villa H; Turrado C; Ramírez-Aportela E; Hoegl A; Nodwell M; Barasoain I; Chacón P; Sieber SA; Andreu JM; López-Rodríguez ML
    ACS Chem Biol; 2015 Mar; 10(3):834-43. PubMed ID: 25486266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of anti-tuberculosis agents that target the cell-division protein FtsZ.
    Lin Y; Zhu N; Han Y; Jiang J; Si S
    J Antibiot (Tokyo); 2014 Sep; 67(9):671-6. PubMed ID: 24984796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of FtsZ inhibitors as potential antibacterial agents.
    Ma S; Ma S
    ChemMedChem; 2012 Jul; 7(7):1161-72. PubMed ID: 22639193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FtsZ inhibition: a promising approach for antistaphylococcal therapy.
    Singh P; Panda D
    Drug News Perspect; 2010 Jun; 23(5):295-304. PubMed ID: 20603653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GTP analogue inhibits polymerization and GTPase activity of the bacterial protein FtsZ without affecting its eukaryotic homologue tubulin.
    Läppchen T; Hartog AF; Pinas VA; Koomen GJ; den Blaauwen T
    Biochemistry; 2005 May; 44(21):7879-84. PubMed ID: 15910002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FtsZ inhibitors as a new genera of antibacterial agents.
    Tripathy S; Sahu SK
    Bioorg Chem; 2019 Oct; 91():103169. PubMed ID: 31398602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
    Li X; Ma S
    Eur J Med Chem; 2015 May; 95():1-15. PubMed ID: 25791674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of agents targeting FtsZ assembly.
    Panda D; Bhattacharya D; Gao QH; Oza PM; Lin HY; Hawkins B; Hibbs DE; Groundwater PW
    Future Med Chem; 2016 Jun; 8(10):1111-32. PubMed ID: 27284850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rhodanine derivative CCR-11 inhibits bacterial proliferation by inhibiting the assembly and GTPase activity of FtsZ.
    Singh P; Jindal B; Surolia A; Panda D
    Biochemistry; 2012 Jul; 51(27):5434-42. PubMed ID: 22703373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics.
    Wang J; Galgoci A; Kodali S; Herath KB; Jayasuriya H; Dorso K; Vicente F; González A; Cully D; Bramhill D; Singh S
    J Biol Chem; 2003 Nov; 278(45):44424-8. PubMed ID: 12952956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
    Haranahalli K; Tong S; Ojima I
    Bioorg Med Chem; 2016 Dec; 24(24):6354-6369. PubMed ID: 27189886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting assembly and bundling of FtsZ as a strategy to inhibit bacterial cell division: a new approach for developing novel antibacterial drugs.
    Beuria TK; Singh P; Surolia A; Panda D
    Biochem J; 2009 Sep; 423(1):61-9. PubMed ID: 19583568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus.
    Andrades J; Campanini J; Vásquez D; Silvestri C; Morales C; Romero J; Mella J
    SAR QSAR Environ Res; 2015; 26(11):925-42. PubMed ID: 26505124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and in vitro inhibition studies of Bacillus anthracis FtsZ: a potential antibacterial target.
    Park HC; Gedi V; Cho JH; Hyun JW; Lee KJ; Kang J; So B; Yoon MY
    Appl Biochem Biotechnol; 2014 Mar; 172(6):3263-70. PubMed ID: 24510482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity.
    Rai D; Singh JK; Roy N; Panda D
    Biochem J; 2008 Feb; 410(1):147-55. PubMed ID: 17953519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting FtsZ for antibacterial therapy: a promising avenue.
    Kapoor S; Panda D
    Expert Opin Ther Targets; 2009 Sep; 13(9):1037-51. PubMed ID: 19659446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics analysis of the effects of GTP, GDP and benzimidazole derivative on structural dynamics of a cell division protein FtsZ from
    Hakeem S; Singh I; Sharma P; Uppal A; Khajuria Y; Verma V; Uversky VN; Chandra R
    J Biomol Struct Dyn; 2019 Oct; 37(16):4361-4373. PubMed ID: 30466358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Pseudomonas aeruginosa FtsZ peptide inhibitors as a tool for development of novel antimicrobials.
    Paradis-Bleau C; Sanschagrin F; Levesque RC
    J Antimicrob Chemother; 2004 Jul; 54(1):278-80. PubMed ID: 15190020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.